Clinical characterization and natural history of chemotherapy‐induced dilated cardiomyopathy

Clinical characterization and natural history of chemotherapy‐induced dilated cardiomyopathy

Abstract Aims Chemotherapy‐induced dilated cardiomyopathy (CI‐DCM) is a well‐recognized phenotype of non‐ischemic dilated cardiomyopathy (DCM), characterized by poor outcomes. However, a detailed comparison between idiopathic DCM (iDCM) and CI‐DCM is still lacking. Methods and results All consecutiv...

Full description

Bibliographic Details
Main Authors: Andrea Lalario, Eva Del Mestre, Michele Lo Casto, Vincenzo Nuzzi, Paolo Manca, Daniel I. Bromage, Giulia Barbati, Marco Merlo, Gianfranco Sinagra, Antonio Cannatà
Format: Article
Language:English
Published: Wiley 2022-10-01
Series:ESC Heart Failure
Subjects:
Chemotherapy induced cardiomyopathy
Dilated cardiomyopathy
Cardiotoxicity
Prognosis
Outcomes
Online Access:https://doi.org/10.1002/ehf2.14045

Internet

https://doi.org/10.1002/ehf2.14045

Similar Items